Black Rock Inc. Pacira Bio Sciences, Inc. Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PCRX
# of Institutions
277Shares Held
48.5MCall Options Held
378KPut Options Held
1.53M-
Vanguard Group Inc Valley Forge, PA5.08MShares$87.4 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.16MShares$37.2 Million0.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.07MShares$35.5 Million0.1% of portfolio
-
State Street Corp Boston, MA1.9MShares$32.7 Million0.0% of portfolio
-
Frontier Capital Management CO LLC1.84MShares$31.6 Million0.55% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $787M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...